Stent

Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies

Improved materials may allow stents, tiny metal scaffolds inserted into blood vessels, to better deliver beneficial genes to patients with heart disease, by reducing the risk of inflammation that often negates initial benefits. The new technique, using a compound that binds in an extremely thin layer to bare metal surfaces, may have potential uses in other areas of medicine that make use of metal...

Stent at Biology Products

No data found

Search Stent biology products at Google

Search Stent biology products at Yahoo

Search Stent biology products at Msn

Stent at Biology Technology

Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance

Stratagene transfection reagent offersimproved, consistent transfections for both adherent cells and cells growing insuspension. In this article, we summarize the results of several experimentsthat characterize the eff...

Kauffman study shows consistent entrepreneurial growth

...

Health-care eyes focus on San Francisco, war of the stents

On Sunday, Boston Scientific stepped into the fray yet again with its determi...

Medical College discovery leads to new stents

MILWAUKEE An investigation of how blood flows through stents after opening clogged arteries has led a team of researchers at the in Milwaukee to suggest that stents designed with thinner and fewer linkages may be the basis of a new generation of stents. Their findings a...

Stent at Medicine News

Coronary stent leads to complications

It is believed that the rate of clot formation inside a coronary stent is three times higher than the previous procedures. Now a days, the majority of angioplasties involve placement of a stent - a tiny metal device, inside the coronary artery to keep it open. But the very act of placing a stent in the artery irritates the vessel walls and may promote formation of a clot - ironically, the actual...

Stent shows promise in keeping arteries open

A new approach to keeping heart arteries flowing smoothly after angioplasty shows surprising success in early testing. Doctors released the longest follow-up with the new technique - the drug-coated stent. //In testing on 50 patients over 3 years, they found it to be 100 percent effective. More than 2 million Americans undergo angioplasty annually, and the new approach is likely to b...

Failure of Drug-Coated Stent

Evidence is growing that stents with certain drugs helps them do a better job of keeping blood vessels open after these vessels have been cleared surgically. But a new report suggests not all drugs work equally well.// Researchers found that stents coated with a derivative of the cancer drug paclitaxel - which inhibits cell division - failed to keep blood vessels open in the majority of a small g...

Lyme disease is a persistent problem

A new trial shows that the symptoms of Lyme disease linger despite antibiotic treatment.Lyme disease, caused by a bacterium that lives in tiny ticks, sometimes produces very long-lasting fatigue and cognitive problems. Even though antibiotic treatment is standard, researchers in Texas feel that this treatment would not be enough to clear up the problem.// They studied 40 Lyme patien...

Abbott Laboratories to buy Biocompatibles' cardiovascular stent business

Abbott Laboratories said it has agreed to acquire the cardiovascular stent business of Biocompatibles International PLC for $234.5 million in cash. Abbott said the deal will strengthen its portfolio of products and will expand its international presence in the vascular business for polymer-coated stents - tiny metal tubes that keep blood vessels open.// Abbott has been the exclusive U...

More>>

Stent at Medicine Products

Cypher Stent

Description:The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, sirolimus elutes into the vessel wall and impedes the process of neointimal hyperplasia, thereby significantly reducing the incidence of in-stent restenosis....
Company:Cordis Corporation

Cypher Sirolimus-eluting Coronary Stent

Description:The CYPHER Sirolimus-eluting Coronary Stent consists of a proven antiproliferative drug, called "sirolimus", a controlled-release polymer, and a closed-cell stent delivery platform. Upon placement, sirolimus elutes into the vessel wall and impedes the process of neointimal hyperplasia, thereby significantly reducing the incidence of in-stent restenosis....
Company:Cordis Corporation

MULTI-LINK OTW PIXEL Coronary Stent System

Description:The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
Company:Guidant Corporation

MULTI-LINK RX PIXEL Coronary Stent System

Description:The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
Company:Guidant Corporation

Express Coronary Stent System

Description:A fusion of first class deliverability, acute angiographic results and excellent versatility....
Company:Boston Scientific Corporation

More>>

Stent at Medicine Technology

New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes

* Significant blood sugar reductions seen across range ofpatient populations, including varied ethnic groups, the elderly,and those at high risk of developing diabetes * Galvus lowers blood sugar when added to a sulfonylurea,reinforcing efficacy in combination with commonly used diabetesmedicines * Data confirm good tolerability in humans with studies showingincidence of sid...

To Stent or Not: Is That the Question?

Reporting of COURAGE study results confused the public about theneed and benefits of angioplasty PORTLAND, Ore., June 07, 2007 /PRNewswire/ -- The onslaught ofanti-stent news reports over the past few months has shaped thepublic's view that angioplasty doesn't work and its use shoulddecrease. Confused by the media coverage, patients have extensivelyquestioned their cardiologists about the...

New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings

Registry Analysis Published in Journal Heart Finds Taxus Stent,Implantation of Multiple Stents and Small Vessel Size To BeIndependent Predictors of Need for Another Procedure MIAMI LAKES, Fla., June 4, 2007 /PRNewswire via COMTEX NewsNetwork/ -- An analysis of data from the Western Denmark HeartRegistry found that patients who received the CYPHER(R)Sirolimus-eluting Coronary...

Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology

NATICK, Mass., June 04, 2007 /PRNewswire-FirstCall/ -- BostonScientific Corporation today welcomed the publication of an articlein the Journal of of Cardiology (JACC) reviewing the TAXUS ATLASclinical trial, which evaluates the Company's second-generationTAXUS(R) Liberte(TM)(1) paclitaxel-eluting stent system. Thearticle in the April 24 edition of JACC concluded that the shorterprocedure...

Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents

Risk of Late Thrombosis is Minimized with Genous Stent BARCELONA, Spain, May 23, 2007 /PRNewswire/ -- The efficacy ofOrbusNeich's Genous(TM) Bio-engineered R stent compares favorablyto that of drug-eluting stents, while the risk of late thrombosisis minimized with the Genous stent, according to an interimanalysis of post-marketing data presented today by Robbert deWinter, M.D., Ph.D., at...

More>>

Stent at Medicine Dictionary

Stent

<A href="http:/ / www.healthcentral.com/ ency/ 408/ 002303.h...